Indication

Respiratory cystic fibrosis with Pseudomonas aeruginosa colonization

Respiratory cystic fibrosis with *Pseudomonas aeruginosa* colonization refers to the persistent or recurrent presence of the opportunistic gram-negative bacterium *Pseudomonas aeruginosa* within the tracheobronchial tree of patients with cystic fibrosis. Read more about Respiratory cystic fibrosis with Pseudomonas aeruginosa colonization

31 drugs 23 manufacturers

Advertisement

Drugs that treat it

Common Respiratory cystic fibrosis with Pseudomonas aeruginosa colonization therapies.

Showing 28–31 of 31 drugs

Filter & compare in the drug finder →Opens the drug finder with Respiratory cystic fibrosis with Pseudomonas aeruginosa colonization preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Respiratory cystic fibrosis with Pseudomonas aeruginosa colonization.

Respiratory cystic fibrosis with *Pseudomonas aeruginosa* colonization refers to the persistent or recurrent presence of the opportunistic gram-negative bacterium *Pseudomonas aeruginosa* within the tracheobronchial tree of patients with cystic fibrosis.

In this population, defective cystic fibrosis transmembrane conductance regulator (CFTR) function leads to dehydrated, hyperviscous airway secretions and impaired mucociliary clearance, creating an ideal niche for bacterial adherence and proliferation.

Colonization often transitions from early, intermittent non-mucoid strains to chronic infection characterized by biofilm-forming, mucoid phenotypes that resist host defenses.

This clinical state triggers sustained airway inflammation, accelerated pulmonary architecture damage, worsening airflow obstruction, and an elevated risk of acute pulmonary exacerbations.

Personalize your experience

Follow Respiratory cystic fibrosis with Pseudomonas aeruginosa colonization and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it